Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome

Journal of Neuroimmunology

Volumn 286, Issue , 2015, Pages 42-47

  Chan, Adeline ^a   Yan, Jun ^a   Csurhes, Peter ^a   Greer, Judith ^a   McCombe, Pamela ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute ischemic stroke; Brain derived neurotrophic factor; Flow cytometry; FoxP3; Neuroprotection; Protective immunity; Regulatory T cells; Stroke outcome

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD27 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BRAIN ISCHEMIA; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; BLOOD; CELL CULTURE; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; YOUNG ADULT;

EID: 84939560213     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.06.013     Document Type: Article

References (32)

1. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
2. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
3. Brea D., Agulla J., Rodriguez-Yanez M., Barral D., Ramos-Cabrer P., Campos F., Almeida A., Davalos A., Castillo J. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J. Cell. Mol. Med. 2014, 18:1571-1579.
4. Chang D.J., Lee N., Choi C., Jeon I., Oh S.H., Shin D.A., Hwang T.S., Lee H.J., Kim S.U., Moon H., Hong K.S., Kang K.S., Song J. Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion. Cell Transplant. 2013, 22:1441-1452.
5. Chen S., Wu H., Klebe D., Hong Y., Zhang J., Tang J. Regulatory T cell in stroke: a new paradigm for immune regulation. Clin. Dev. Immunol. 2013, 2013:689827.
6. Di Lazzaro V., Profice P., Pilato F., Dileone M., Florio L., Tonali P.A., Angelucci F. BDNF plasma levels in acute stroke. Neurosci. Lett. 2007, 422:128-130.
7. Ferraro A., D'Alise A.M., Raj T., Asinovski N., Phillips R., Ergun A., Replogle J.M., Bernier A., Laffel L., Stranger B.E., De Jager P.L., Mathis D., Benoist C. Interindividual variation in human T regulatory cells. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E1111-E1120.
8. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
9. Gogishvili T., Luhder F., Goebbels S., Beer-Hammer S., Pfeffer K., Hunig T. Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion. Eur. J. Immunol. 2013, 43:188-193.
10. Greenberg M.E., Xu B., Lu B., Hempstead B.L. New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci. 2009, 29:12764-12767.
11. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
12. Jeong D.S., Kim S.M., Lim J.Y., Ryu C.H., Jun J.A., Jeun S.S. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischaemic stroke model. BioMed Res. Int. 2014, 129-145.
13. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
14. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 1999, 189:865-870.
15. Kim H.J., Leeds P., Chuang D.M. The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J. Neurochem. 2009, 110:1226-1240.
16. Kleinschnitz C., Kraft P., Dreykluft A., Hagedorn I., Gobel K., Schuhmann M.K., Langhauser F., Helluy X., Schwarz T., Bittner S., Mayer C.T., Brede M., Varallyay C., Pham M., Bendszus M., Jakob P., Magnus T., Meuth S.G., Iwakura Y., Zernecke A., Sparwasser T., Nieswandt B., Stoll G., Wiendl H. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013, 121:679-691.
17. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 2009, 15:192-199.
18. Mahoney F.I., Barthel D.W. Functional evaluation: the barthel index. Md State Med. J. 1965, 14:61-65.
19. McCombe P.A., Read S.J. Immune and inflammatory responses to stroke: good or bad?. Int. J. Stroke 2008, 3:254-265.
20. Moustafa R.R., Baron J.C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br. J. Pharmacol. 2008, 153(Suppl. 1):S44-S54.
21. Na S.Y., Mracsko E., Liesz A., Hunig T., Veltkamp R. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice. Stroke 2015, 46:212-220.
22. Schabitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 2000, 31:2212-2217.
23. Sulter G., Steen C., De K.J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999, 30:1538-1541.
24. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008, 9:239-244.
25. Wan Y.Y. Multi-tasking of helper T cells. Immunology 2010, 130:166-171.
26. Xu X., Li M., Jiang Y. The paradox role of regulatory T cells in ischemic stroke. ScientificWorldJournal 2013, 2013:174373.
27. Yan J., Greer J.M., Etherington K., Cadigan G.P., Cavanagh H., Henderson R.D., O'sullivan J.D., Pandian J.D., Read S.J., McCombe P.A. Immune activation in the peripheral blood of patients with acute ischemic stroke. J. Neuroimmunol. 2009, 206:112-117.
28. Yan J., Greer J.M., McCombe P.A. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J. Neuroimmunol. 2012, 246:78-84.
29. Yan J., Read S.J., Henderson R.D., Hull R., O'sullivan J.D., McCombe P.A., Greer J.M. Frequency and function of regulatory T cells after ischaemic stroke in humans. J. Neuroimmunol. 2012, 243:89-94.
30. Yilmaz G., Arumugam T.V., Stokes K.Y., Granger D.N. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113:2105-2112.
31. Zhang Y., Pardridge W.M. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 2006, 1111:227-229.
32. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002, 125:2381-2391.